Steatotic liver disease (SLD) displays a dynamic and complex disease phenotype.
Consequently, the metabolic dysfunction-associated steatotic liver disease …

Background Recent studies suggest that tirzepatide, a dual glucose-dependent
insulinotropic-peptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA), has …

Background Common metabolic diseases, such as type 2 diabetes mellitus (T2DM),
hypertension, obesity, hypercholesterolemia, and metabolic dysfunction-associated steatotic …

Objective Metabolic dysfunction-associated steatotic liver disease (MASLD) and
cardiometabolic conditions affect populations across economic strata. Nevertheless, there …

Aims The prediction of future trends in cardiovascular disease (CVD) mortality and their risk
factors can assist policy-makers in healthcare planning. This study aims to project geospatial …

The 21st century is characterized by an increasing incidence and prevalence of obesity and
the burden of its associated comorbidities, especially cardiometabolic diseases, which are …

Background Given the rapidly growing burden of cardiovascular disease (CVD) in Asia, this
study forecasts the CVD burden and associated risk factors in Asia from 2025 to 2050 …

Background: Epicardial adipose tissue (EAT) has garnered attention as a prognostic and
risk stratification factor for cardiovascular disease. This study, via meta-analyses, evaluates …

Protein kinases (PKs), one of the largest protein families, can be further divided into different
groups based on their substrate or structure and function. PKs are important signaling …

Background Non‐alcoholic fatty liver disease (NAFLD) represents a significant health threat
worldwide. The growing trend towards an aging population, along with an alarming rise in …